Drug Type Dendritic cell vaccine |
Synonyms DC Vaccine Adjuvant With STING-Dependent Activators (STAVs) |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Phase 1 | US | 30 Nov 2023 | |
Acute Myeloid Leukemia | Phase 1 | US | 30 Nov 2023 | |
Adult T-Cell Leukemia-Lymphoma | Phase 1 | US | 30 Nov 2023 | |
Refractory Leukemia | Phase 1 | US | 30 Nov 2023 |